Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Qiagen (QGEN) Other Operating Expenses (2016 - 2025)

Qiagen's Other Operating Expenses history spans 17 years, with the latest figure at $171.6 million for Q4 2025.

  • On a quarterly basis, Other Operating Expenses fell 5.67% to $171.6 million in Q4 2025 year-over-year; TTM through Mar 2026 was $306.0 million, a 18.13% decrease, with the full-year FY2025 number at $272.2 million, up 5.83% from a year prior.
  • Other Operating Expenses hit $171.6 million in Q4 2025 for Qiagen, up from $64.0 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for QGEN hit a ceiling of $201.2 million in Q4 2021 and a floor of $59.5 million in Q1 2024.
  • Historically, Other Operating Expenses has averaged $105.1 million across 5 years, with a median of $69.4 million in 2022.
  • Biggest five-year swings in Other Operating Expenses: soared 58.63% in 2021 and later plummeted 42.58% in 2022.
  • Tracing QGEN's Other Operating Expenses over 5 years: stood at $201.2 million in 2021, then decreased by 4.33% to $192.4 million in 2022, then dropped by 2.13% to $188.3 million in 2023, then dropped by 3.43% to $181.9 million in 2024, then dropped by 5.67% to $171.6 million in 2025.
  • Business Quant data shows Other Operating Expenses for QGEN at $171.6 million in Q4 2025, $64.0 million in Q3 2025, and $70.4 million in Q2 2025.